Professor Petro Terblanche has a successful track record in the strategic and operational management of technology intensive organizations. She has played a key part in the design and implementation of South Africa’s biotechnology strategy. She holds the position of Managing Director of Afrigen Biologics (Pty)Ltd based in Cape Town, South Africa.

Petro Terblanche, née en 1959 à Brits, est une scientifique sud-africaine et la directrice générale d’Afrigen, une société de biotechnologie qui a mis au point un vaccin contre le COVID-19, en utilisant le concept d'ARN messager. Afrigen participe à une diffusion du savoir-faire sur cette technologie d’ARN messager vers les pays non ...

She has been the lead negotiator on several licence agreements in the field of food, fine chemical and pharmaceuticals and has been instrumental in the creation of start-up companies for profit and non-profit purposes. She has played a key role in the development and implementation of South Africa's Biotechnology strategy since 1999.

Petro Terblanche has a track record in the successful strategic management of technology based organizations and the translation of research into innovation.

2023年6月17日 · Petro Terblanche, the Managing Director of Afrigen Biologics and Vaccines based in Cape Town, South Africa, insists that her varied career has been unplanned.

2024年5月17日 · Professor Petro Terblanche has played a key part in the design and implementation of South Africa’s biotechnology strategy. She holds the position of Chief Executive Officer of Afrigen Biologics (Pty)Ltd based in Cape Town, South Africa.

Professor Petro Terblanche has a successful track record in the strategic and operational management of technology intensive organizations. She has played a key part in the design and implementation of South Africa’s biotechnology strategy. She holds the position of Managing Director of Afrigen Biologics (Pty)Ltd based in Cape Town, South Africa.

2023年6月26日 · Petro Terblanche, the Managing Director of Afrigen Biologics and Vaccines based in Cape Town, South Africa, insists that her varied career has been unplanned. What kind of a plan would take you from a starting point in animal biology to the leadership of a rising biotech company via data management in cancer trials, environmental epidemiology,

2022年9月1日 · Terblanche is the managing director at the biotechnology company, Afrigen. After four months of hard work, the team had successfully completed the first step of making an mRNA vaccine for COVID-19. They had gotten the genetic coding into its carrier – a lipid nanoparticle.